Get started
Alivus Life Sciences LtdAlivus Life Sciences LtdAlivus Life Sciences Ltd

Alivus Life Sciences Ltd

No trades
See on Supercharts
Overview
Financials Ideas Discussions Technicals Forecast Seasonals

ALIVUS chart


Full chart

ALIVUS upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪113.09 B‬ INR
Dividend yield (indicated)
0.54%
Price to earnings Ratio (TTM)
23.05
Basic EPS (TTM)
40.45 INR
Net income (FY)
‪4.86 B‬ INR
Revenue (FY)
‪23.72 B‬ INR
Shares float
‪30.66 M‬
Beta (1Y)
0.89

Employees


Employees (FY)
‪3.94 K‬
Change (1Y)
+467 +13.46%
Revenue / Employee (1Y)
‪6.03 M‬ INR
Net income / Employee (1Y)
‪1.23 M‬ INR

About Alivus Life Sciences Ltd


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Yasir Rawjee
Website
glenmarklifesciences.com
Headquarters
Mumbai
Founded
2011
ISIN
INE03Q201024
FIGI
BBG011WT9KP6
Alivus Life Sciences Ltd. engages in the provision of development and manufacture of non-commoditized active pharmaceutical ingredients. It operates through the Within India and Outside India geographical segments. Its products focus on chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management, and diabetes. The company was founded on June 23, 2011 and is headquartered in Mumbai, India.

Check out other big names from the same industry as ALIVUS.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ALIVUS is 920.55 INR — it has decreased by −0.43% in the past 24 hours. Watch Alivus Life Sciences Ltd stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Alivus Life Sciences Ltd stocks are traded under the ticker ALIVUS.
ALIVUS stock has fallen by −1.93% compared to the previous week, the month change is a −1.96% fall, over the last year Alivus Life Sciences Ltd has showed a −15.78% decrease.
We've gathered analysts' opinions on Alivus Life Sciences Ltd future price: according to them, ALIVUS price has a max estimate of 1,382.00 INR and a min estimate of 1,109.00 INR. Watch ALIVUS chart and read a more detailed Alivus Life Sciences Ltd stock forecast: see what analysts think of Alivus Life Sciences Ltd and suggest that you do with its stocks.
ALIVUS reached its all-time high on Sep 16, 2024 with the price of 1,335.10 INR, and its all-time low was 370.00 INR and was reached on Sep 28, 2022. View more price dynamics on ALIVUS chart.
See other stocks reaching their highest and lowest prices.
ALIVUS stock is 1.54% volatile and has beta coefficient of 0.89. Track Alivus Life Sciences Ltd stock price on the chart and check out the list of the most volatile stocks — is Alivus Life Sciences Ltd there?
Today Alivus Life Sciences Ltd has the market capitalization of ‪113.05 B‬, it has decreased by −2.72% over the last week.
Yes, you can track Alivus Life Sciences Ltd financials in yearly and quarterly reports right on TradingView.
Alivus Life Sciences Ltd is going to release the next earnings report on Oct 17, 2025. Keep track of upcoming events with our Earnings Calendar.
ALIVUS net income for the last quarter is ‪1.22 B‬ INR, while the quarter before that showed ‪1.42 B‬ INR of net income which accounts for −14.33% change. Track more Alivus Life Sciences Ltd financial stats to get the full picture.
Yes, ALIVUS dividends are paid annually. The last dividend per share was 5.00 INR. As of today, Dividend Yield (TTM)% is 0.00%. Tracking Alivus Life Sciences Ltd dividends might help you take more informed decisions.
Alivus Life Sciences Ltd dividend yield was 0.46% in 2024, and payout ratio reached 12.62%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 8, 2025, the company has ‪3.94 K‬ employees. See our rating of the largest employees — is Alivus Life Sciences Ltd on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Alivus Life Sciences Ltd EBITDA is ‪6.95 B‬ INR, and current EBITDA margin is 28.74%. See more stats in Alivus Life Sciences Ltd financial statements.
Like other stocks, ALIVUS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Alivus Life Sciences Ltd stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Alivus Life Sciences Ltd technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Alivus Life Sciences Ltd stock shows the sell signal. See more of Alivus Life Sciences Ltd technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.